Electronics, Pharma Sectors Receive 70% of PLI Scheme Payout in FY25: Government Data

New Delhi – The electronics and pharmaceutical industries have emerged as the top beneficiaries of the Production-Linked Incentive (PLI) scheme in the financial year 2024-25, receiving nearly 70% of the total funds disbursed, according to official government data.

Out of a total of ?10,114 crore released under the scheme during the year, the electronics sector secured ?5,732 crore, while the pharmaceutical sector received ?2,328 crore.

Launched in 2021 to promote domestic manufacturing, the PLI scheme initially targeted 14 key sectors. Since its inception, it has significantly contributed to strengthening India’s industrial base and boosting high-value exports.

The scheme’s success is especially evident in the electronics sector, which has now become one of India’s top three export categories. In 2024-25, electronics exports surged by 32.46%, climbing from $29.12 billion in 2023-24 to $38.58 billion — a substantial rise from $15.7 billion in 2021-22 and $23.6 billion in 2022-23.

One of the standout performers within the electronics category was computer hardware and peripherals, which saw a staggering 101% export growth — doubling from $0.7 billion to $1.4 billion in FY25.

Key markets for Indian electronics included the United Arab Emirates, the United States, the Netherlands, the United Kingdom, and Italy.

The pharmaceutical sector also maintained strong momentum. Indian drug and pharmaceutical products now reach over 200 countries worldwide. In FY25, pharma exports rose by nearly 10% to $30.5 billion, reinforcing India’s growing influence in the global healthcare and pharmaceutical space.

The latest data underscores the growing impact of the PLI scheme in driving India’s manufacturing and export goals — particularly in sectors where the country is rapidly emerging as a global leader.

With inputs from IANS